Urology Tablet Franchise in Ahmedabad

Urinary Disorder Medicine Supplier in Mumbai

Overactive Bladder Medicine Distributor in Delhi

Darifenacin Tablet Manufacturer in Bangalore

Urology Tablet Stockist in Hyderabad
Urology Medicine Exporter in Chandigarh

Home/Products /darifenacin-15mg-tablet

Darihype 15 Tablet

Composition : Darifenacin (15mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Darihype 15 Tablet containing Darifenacin is used for the management of overactive bladder symptoms. It helps in reducing urinary urgency, increased frequency, and urge incontinence.

Darifenacin works as an antimuscarinic agent that relaxes bladder muscles, helping improve bladder control and reduce unwanted urinary contractions.

The tablet is widely prescribed in urology practice for long-term bladder management, leading to consistent demand and repeat usage.

With increasing prevalence of urinary disorders and growing awareness of urological health, this product offers strong business potential for retailers and distributors. Its chronic therapy requirement, steady prescription demand, and broad clinical acceptance make it a reliable product for consistent sales and growth in the urology segment.

Read More

About the Product

Darihype 15 Tablet containing Darifenacin is used for the management of overactive bladder symptoms. It helps in reducing urinary urgency, increased frequency, and urge incontinence.

Darifenacin works as an antimuscarinic agent that relaxes bladder muscles, helping improve bladder control and reduce unwanted urinary contractions.

The tablet is widely prescribed in urology practice for long-term bladder management, leading to consistent demand and repeat usage.

With increasing prevalence of urinary disorders and growing awareness of urological health, this product offers strong business potential for retailers and distributors. Its chronic therapy requirement, steady prescription demand, and broad clinical acceptance make it a reliable product for consistent sales and growth in the urology segment.

Some patients may experience dry mouth, constipation, blurred vision, headache, or dizziness. Rarely, urinary retention or severe allergic reactions may occur and require medical attention.

Darihype 15 Tablet is indicated for the treatment of overactive bladder with symptoms such as urinary urgency, increased frequency of urination, and urge urinary incontinence. It helps improve bladder capacity, reduce urinary leakage, and enhance patient comfort.

This medicine should be used under medical supervision. Use cautiously in patients with glaucoma, urinary retention, gastrointestinal obstruction, or liver disorders. Adequate hydration and monitoring are advised during therapy.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

Strategic Advisory

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation